Bleomycin
Active substance: bleomycin
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · BLEOMYCIN SULFATE 30 [USP'U]/1
United StatesActive
Marketing holder: Hospira, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- BLEOMYCIN SULFATE · 30 [USP'U]/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 12 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-872e-75a6-8cb8-150450e926ee,01a1208e-eaf0-7344-af1e-eb726a25277d,01a1208f-9266-70d0-aa64-440712b8d96c,01a12090-c2f7-736a-b62a-77b665f1c157,01a12090-c2fb-70ca-ac3f-cb12964de837;count=12 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0409-0323
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAMUSCULAR, INTRAPLEURAL, INTRAVENOUS, SUBCUTANEOUS
Sources
- product · openFDA NDC · 0409-0323 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0409-0323 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0409-0323 · Verified 2026-10-09 · open in source